Tirzepatide, a recently approved medication, is generating significant interest in the medical community as a possible treatment for both diabetes, type 2 and reducing body fat. This unique drug works by activating two distinct receptors, GLP-1 and GIP, leading to enhanced glucose control and significant slimming in clinical trials . While initial